_{First a message from our friends at Golden Portfolio [sponsor]}

Most so-called gold analysts don't understand the most fundamental fact about gold: It's not like other investments.

Every few generations...

Gold becomes the only asset investors cannot be without.

That moment is now. I lay it all out for you here – including the four best ways to play the coming gold mania.

Debt is going parabolic as the US added another $1 trillion in debt... in just 71 days.

Confidence in the US dollar is cracking – as other nations dump US Treasuries and buy gold...

And the world is quietly preparing for a monetary reset that will restore gold's crown as the king of monetary assets – this time, permanently.

The current bull market in gold will be the last one of our lifetime – and the last one you'll need if you play your cards right.

For those who act before "gold fever" hits, this cycle could lead to complete financial transformation for you and your family. It's coming.

How do I know?

Because one cutting-edge private company is about to roll out a revolutionary gold investment 5,000 years in the making.

Go here for details before this final gold bull market sees its next leg higher.

Best,

Garrett Goggin, CFA, CMT
Lead Analyst and Founder, Golden Portfolio

Market Movers, Macro Signals, and What Matters Today**

Date: Tuesday, February 10, 2026
Time: Pre-Market (before NYSE/Nasdaq open)

This morning’s tape is a classic display of a market still in macro transition—where headlines and company-specific catalysts are temporarily outweighing broad index trends. The headline action isn’t a broad risk-on or risk-off sweep; instead, it’s dispersion—big winners and big losers across sectors, driven by earnings reactions, regulatory headlines, and positioning ahead of this week’s massive macro catalyst slate.

Most importantly: today’s moves are not random. They are coherent when you read them through the lens of:

Let’s break down the biggest winners and losers this morning, understand why their prices are moving, and highlight what active traders should be watching when the bell rings.

Before we hit names, set the stage:

The major index futures are relatively tight this morning:

This pattern—large cap mildly positive, small cap lagging—is consistent with a tape that is positioning into macro data (the delayed January jobs report Wednesday and February CPI Friday). Market participants are hesitant to lean too hard into directional bets when volatility is poised to spike around these prints.

Weekend news flows were also mixed, and that’s showing up in idiosyncratic dispersion rather than a unified sector move.

With that framework, let’s dive into the names driving attention this morning.

Price Action This Morning:
Pre-market NVO is up ~4–7% — the largest gainer among large-cap names with meaningful volume.

Why It’s Moving:
Today’s biggest top-line move is the continuation of the GLP-1 regulatory narrative: Hims & Hers (HIMS) drastically reversed course on a compounded GLP-1 product and Novo followed with a patent lawsuit, prompting markets to re-weight the probability of compounding enforcement.

Reuters specifically reported that FDA directives and enforcement-oriented language were interpreted by investors as a broader regulatory crackdown on compounded GLP-1 alternatives. In that light, the competitive pressure from low-priced knockoffs is suddenly much smaller than feared. (reuters.com)

Active Trader Angle:
The key here isn’t that Novo’s fundamentals have suddenly exploded (though they remain strong); it’s that regulatory clarity has shifted perceived risk. Traders are rotating out of the “disruption risk” discount and pricing in dominance consolidation.

What to Watch:

Risk Consideration:
This move could be a regulatory relief rally—which can fade if enforcement language weakens or if legal proceedings drag on without decisive wins.

Price Action This Morning:
LLY is up ~2–4% in pre-market, trailing NVO but still showing notable outperformance vs. the broader tape.

Why It’s Moving:
Lilly is often lumped in with GLP-1 growth leaders. Even though today’s headline is centered on Novo’s lawsuit, traders view Lilly as a secondary beneficiary, especially if regulatory tightening limits compounded alternatives.

Active Trader Angle:
LLY’s reaction is less about direct legal involvement and more about relative safety in the GLP-1 complex now that one of the most prominent “copycat threat” narratives has been interrupted.

What to Watch:

Risk Consideration:
If LLY rally becomes purely a sector catch-up trade without fresh catalysts, it can become short-term rotation rather than a sustained uptrend.

Price Action This Morning:
Defensive staples like Coca-Cola (KO), Procter & Gamble (PG), and Walmart (WMT) are up modestly (0.5–1.5%).

Why They’re Moving:
In a macro week with massive data risk, defensive equity exposure tends to creep higher pre-data as traders hedge against volatility spikes.

This is especially true in retail and consumer staples, where earnings tend to be less cyclically sensitive than semiconductors or high-growth tech.

Active Trader Angle:
Defensives rising ahead of data prints may indicate a portion of the market dialing down risk appetite. For active traders, this isn’t a “buy and hold” thesis, but rather a sentiment indicator—if defensives outperform in the next 24–48 hours, risk assets may struggle to hold gains.

Risk Consideration:
Without follow-through, defensive strength can just be position squaring rather than a sustained shift.

Price Action This Morning:
Long-duration Treasury proxies are slightly higher, signaling that fixed-income traders are willing to add duration ahead of macro prints.

Why It’s Moving:
If yields slide even slightly pre-data, it loosens pressure on growth multiples momentarily, and traders will rotate modestly into bond proxies in anticipation of volatility.

Active Trader Angle:
This move doesn’t automatically translate into a broader equity rally—but it reduces yield risk, which can be a necessary condition for risk assets to stabilize.

What to Watch:

Risk Consideration:
Bond proxies can reverse quickly on headline surprises.

Price Action This Morning:
HIMS is sharply lower — double-digit weakness (-10% or more) in pre-market on heavy volume.

Why It’s Moving:
Today’s move isn’t merely profit taking; it’s a risk repricing. After HIMS reversed a previously marketed low-priced GLP-1 offering and regulatory pushback intensified, the stock has been hit as traders reassess its business model durability.

Investors interpreted the patent lawsuit from Novo and FDA enforcement signaling as a structural headwind—not just a temporary hiccup. That’s a classic trigger for multiple compression in high-growth phenotypes that trade on narrative.

Active Trader Angle:
This is a fundamental plus sentiment collapse scenario — the kind that often leads to:

Tactical Consideration:
Short-term traders should treat today’s HIMS action as an event regime, not a simple pullback. That means watching:

Any bounce here should be light and short-lived unless there’s a clear regulatory or legal de-escalation announcement.

Price Action This Morning:
KD is under pressure again — down sharply.

Why It’s Moving:
Last night’s earnings were not merely a miss—they contained a credibility shock: delayed SEC filings, an internal controls review, and a CFO departure. That’s a toxic combination that often triggers institutional de-risking until clarity improves.

This isn’t typical “guide down/revenue miss” noise — this is confidence risk, which is why the stock is acting like a loser, not just a laggard.

Active Trader Angle:
When a company’s internal controls are part of the story, the means of recovery is longer and more nuanced:

In other words, this is not a simple trade — it’s a structural repositioning.

Tactical Consideration:
Position sizing should be small and risk defined. If you are trading KD, you’re trading uncertainty, not a clear narrative.

Price Action This Morning:
MNDY is down significantly as the market digs into its guidance.

Why It’s Moving:
MNDY reported a solid quarter (beat on top and bottom lines), but guidance was cut meaningfully—operating income and full-year expectations came in well below Street models.

In a market where guidance matters more than results, especially in software, that’s enough to send the stock down hard.

This is part of a broader pattern we’re seeing in growth software: beat and drop is increasingly common in times of macro uncertainty because investors discount future earnings more aggressively.

Active Trader Angle:
When guidance is the focus, the volatility term premium usually goes up, and buyers move to the sidelines. That creates:

Tactical Consideration:
Short-duration options structures or defined risk spreads are often more effective than straight long positions in this regime.

Price Action This Morning:
PGY is down materially in pre-market after reporting earnings where revenue came in below expectations — even though being profitable and cash flow–positive.

Why It’s Moving:
This is another version of the “guidance/growth narrative outweighs fundamentals” environment. PGY’s beat elsewhere couldn’t offset the revenue miss, which traders see as a leading signal for slower growth ahead.

In fintech and high-growth fintech adjacent names, revenue is often treated like the most important variable for multiple expansion or contraction.

Active Trader Angle:
This is a reminder that in environments with tight credit expectations and macro uncertainty, revenue miss stories amplify more than they used to.

Tactical Consideration:
Look for whether the selloff accelerates after initial flush (bearish continuation) or compresses volume (possible short squeeze setup).

Price Action This Morning:
TSLA is modestly lower pre-market.

Why It’s Moving:
Tesla isn’t reacting to its own earnings or a specific catalyst this morning. Instead, its weakness seems to reflect broader growth asset digestion amid macro caution.

U.S. equity futures are not pushing risk in a sustained way ahead of jobs and CPI, and names like Tesla—which have historically led risk appetite phases—are simply marking time.

Active Trader Angle:
When a sentiment “tell” stock like Tesla is lukewarm or drifting down while defensive names gain, it suggests caution from institutional money, not conviction.

Tactical Consideration:
This is a sentiment observation, not a trade idea by itself. Use relative strength comparisons between TSLA and other growth names to gauge broader risk appetite.

When you look across:

Winners:

Losers:

There’s a coherent message:

This qualifies today as an active trader regime where dispersion beats directional bias. It’s not a broad bull or bear move. It’s a story-driven environment where specific narratives dominate specific tickers.

Here’s how active traders should think about positioning in the next few hours:

Many of these moves are headline reactions. Do not anchor simply on price change — anchor on why the price is moving. That’s where the edge comes from.

Ask:

Earnings reactions (KD, PGY) and regulatory shocks (HIMS) often inflate implied volatility. Naked options are expensive and dangerous. Instead, favor:

High volume on down moves (e.g., HIMS, KD) means participation loss from buyers. If that persists, it’s a structural short bias, not a kneejerk pullback.

Watch for:

With Jobs on Wednesday and CPI on Friday, rotations are likely to persist. The breadth of leadership matters more than any single index print:

In dispersive markets:

Make sure your trades align with the dominant regime, not your personal preference.

This morning shows a market that is hesitant at the macro level but decisive at the narrative level. That’s good news for active traders who can interpret specific catalysts and ride volatility intelligently.

Today’s edge:

When the tape cares more about earnings nuance, regulatory risk, and guidance credibility than broad economic direction, that’s your signal to favor idiosyncratic setups and tactical risk controls over pure market direction bets.

_{This commentary is for informational and educational purposes only and does not constitute investment advice. All market strategies involve risk, and past performance is not indicative of future results. Readers should conduct their own analysis or consult a licensed financial professional before making investment decisions.}